Gene Therapy Restores Some Vision in Congenital Amaurosis

by Medscape • 2015/11/16 • 0 Comments

A single injection of AAV2-hRPE65v2 (SPK-RPE65, Spark Therapeutics, Inc) improved mobility in different light levels and improved light sensitivity more than 100-fold.
Medscape Medical News

Full Story →

← AAO continues to preserve the value of its members

Evena Medical Launches First Smart Glasses for Clinicians at MEDICA 2015 with Ultrasound for Deep Tissue Vascular Imaging →

Post navigation